相关实验视频
Updated: Jul 29, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
15.9K
针对性交付的抗癌药物装载充电PLGA聚合物纳米粒子使用静电场的目标交付
Seyyed Hossein Miraghaie1,2,3, Ashkan Zandi2,4, Zahra Davari2,3
1Department of Polymer Engineering, Kish International Campus, University of Tehran, Kish Island, 79416-55664, Iran.
Macromolecular bioscience
|July 3, 2023
概括
纯正静电电荷 (PPEC) 通过吸引药物载荷纳米粒子 (DLN) 到瘤来增强向化疗. 这种方法实现了有效的癌症治疗,药物剂量显著降低,副作用最小.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 侵袭性癌细胞激烈地增殖和代谢.
- 向药物输送的目的是尽量减少非向器官的副作用.
- 目前的化疗通常涉及高度药物和全身毒性.
研究的目的:
- 调查使用纯正静电电荷 (PPECs) 针对药物载荷纳米粒子 (DLNs) 的定向输送.
- 在小鼠模型中评估PPEC辅助化疗的疗效和安全性.
- 评估药物的受控释放,从DLN上加盖了聚乳合糖化物 (PLGA) 和聚乙烯醇 (PVA) 的药物.
主要方法:
- 使用PLGA和PVA开发的DLN,以稳定的负电荷为特征.
- 在小鼠模型中,应用了一个带电的贴片,将PPEC送到瘤区域.
- 使用生物化学,放射学和组织学方法测试药物释放和瘤抑制.
- 在非向器官 (老鼠肝) 中评估药物度和副作用.
主要成果:
- 由于稳定的负收费,DLN对PPEC具有很强的吸引力.
- 在瘤部位观察到可控,有针对性的药物释放.
- 与传统化疗 (2 mg kg-1) 相比,通过较低度 (0.75 mg kg-1) 实现显著的药物输送.
- 在非向器官中,已被证明是微不足道的副作用.
结论:
- PPECs促进了DLN的向传递和受控释放到瘤部位.
- 这种PPEC辅助的方法可以有效地进行局部化疗,降低药物剂量和最小的毒性.
- PPECs显示出先进的向化疗具有更好的安全性概况的显著潜力.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

